Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,054.28
1,047.10
998.83
945.67
940.24
1,076.63
900.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,054.28
1,047.10
998.83
945.67
940.24
1,076.63
900.30
Raw Material Cost
284.01
282.22
278.13
267.34
295.80
328.91
292.09
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.97
4.35
4.01
4.34
3.88
3.95
3.54
Selling and Distribution Expenses
504.06
468.07
439.24
412.39
425.47
440.33
358.72
Other Expenses
11.09
9.25
10.04
8.95
8.17
9.45
14.10
Total Expenditure (Excl Depreciation)
903.95
847.16
821.80
773.61
806.87
867.71
795.39
Operating Profit (PBDIT) excl Other Income
150.29999999999998
199.89999999999998
177
172.10000000000002
133.4
208.9
104.9
Other Income
35.71
33.72
50.70
20.29
39.06
35.87
43.07
Operating Profit (PBDIT)
297.74
342.23
153.92
286.35
268.94
339.06
245.43
Interest
4.97
4.35
4.01
4.34
3.88
3.95
3.54
Exceptional Items
2.91
2.82
6.60
2.53
3.91
1.47
-48.06
Gross Profit (PBDT)
770.27
764.88
720.70
678.32
644.43
747.72
608.21
Depreciation
108.56
108.56
105.14
105.14
99.34
99.34
101.19
Profit Before Tax
187.13
232.15
51.37
179.41
169.64
237.24
92.64
Tax
16.14
25.10
-34.84
9.65
19.93
32.62
-11.84
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
164.75
200.33
91.85
165.62
143.83
200.27
100.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
164.75
200.33
91.85
165.62
143.83
200.27
100.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.76
2.53
1.21
2.17
2.36
-2.15
2.74
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
172.51
202.86
93.07
167.79
146.19
198.11
103.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
8,538.96
8,918.36
8,712.15
8,606.63
7,834.29
8,226.39
8,018.99
Earnings per share (EPS)
0.15
0.18
0.08
0.15
0.13
0.18
0.09
Diluted Earnings per share
0.15
0.18
0.08
0.15
0.13
0.18
0.09
Operating Profit Margin (Excl OI)
14.56%
19.1%
-0.19%
17.02%
13.88%
18.93%
11.24%
Gross Profit Margin
28.05%
32.54%
15.67%
30.09%
28.61%
31.26%
21.53%
PAT Margin
15.63%
19.13%
9.2%
17.51%
15.3%
18.6%
11.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 12.14% vs 19.98% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 17.99% vs 15.03% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 13.96% vs 15.47% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 28.21% vs -13.33% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Shenzhen Salubris Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,054.28
0
1,054.28
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,054.28
0
1,054.28
Raw Material Cost
284.01
0
284.01
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.97
0
4.97
Selling and Distribution Expenses
504.06
0
504.06
Other Expenses
11.09
0.00
11.09
Total Expenditure (Excl Depreciation)
903.95
0
903.95
Operating Profit (PBDIT) excl Other Income
150.33
0.00
150.33
Other Income
35.71
0
35.71
Operating Profit (PBDIT)
297.74
0
297.74
Interest
4.97
0
4.97
Exceptional Items
2.91
0
2.91
Gross Profit (PBDT)
770.27
0
770.27
Depreciation
108.56
0
108.56
Profit Before Tax
187.13
0
187.13
Tax
16.14
0
16.14
Provisions and contingencies
0
0
0.00
Profit After Tax
164.75
0
164.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
164.75
0
164.75
Share in Profit of Associates
0
0
0.00
Minority Interest
7.76
0
7.76
Other related items
0.00
0.00
0.00
Consolidated Net Profit
172.51
0
172.51
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,538.96
0
8,538.96
Earnings per share (EPS)
0.15
0
0.15
Diluted Earnings per share
0.15
0
0.15
Operating Profit Margin (Excl OI)
14.56%
0%
0.00
14.56%
Gross Profit Margin
28.05%
0%
0.00
28.05%
PAT Margin
15.63%
0%
0.00
15.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 105.43 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 0.69% vs 4.84% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 12.14% vs 19.98% in Jun 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 17.25 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -14.98% vs 117.94% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 17.99% vs 15.03% in Jun 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.20 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is -15.07% vs 198.93% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 13.96% vs 15.47% in Jun 2024
Quarterly - Interest
Interest 0.50 Million
in Jun 2025Figures in Million
QoQ Growth in quarter ended Jun 2025 is 16.28% vs 7.50% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 28.21% vs -13.33% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.56%
in Jun 2025Figures in %
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
